Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 27, 2019

Regeneron, Sanofi get FDA nod for Dupixent to treat chronic rhinosinusitis with nasal polyps

Regeneron Pharmaceuticals and Sanofi have secured approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) to treat adults with nasal polyps accompanied by chronic rhinosinusitis.

Continue
Image: The US FDA’s Center for Drug Evaluation and Research. Photo: courtesy of The U.S. Food and Drug Administration.
June 26, 2019

AbbVie to buy Irish pharmaceutical firm Allergan for £49.4bn

Image: Allergan’s site in Westport, Ireland. Photo: courtesy of Allergan.
June 26, 2019

TILT Biotherapeutics to evaluate TILT-123, avelumab combo in solid tumours

Image: TILT-123 to be evaluated in combination with avelumab for the treatment of solid tumours. Photo: courtesy of Colin Behrens/Pixabay.

Contracts

May 22, 2019

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Image: WuXi Vaccines will build an integrated vaccine manufacturing facility. Photo: courtesy of Arek Socha / Pixabay.

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Deals

Deals June 18, 2019

Pfizer to buy Array BioPharma for £9.06bn

Pharmaceutical Business Review

Dassault Systèmes to buy Medidata Solutions for £4.5bn

Aptar acquires Nanopharm and Gateway Analytical to accelerate customer drug development

Merck to buy biopharmaceutical firm Tilos Therapeutics in £608m deal

Popular

  1. Imbrium initiates phase 2 study of IMB-115 in insomnia associated with alcohol cessation
  2. NantKwest launches phase 1 trial with targeted PD-L1 t-haNK cell therapy in patients with solid tumors
  3. Janssen announces collaboration with US universities to expand data science research in healthcare
  4. RIBOMIC announces positive top-line results from phase 1/2a trial of rbm-007 in wet AMD
  5. Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease

PRESS RELEASES

SCHOTT RealView™ Glass Wafers Expand Field of View in Augmented and Mixed Reality
SCHOTT RealView™ Glass Wafers Expand Field of View in Augmented and Mixed Reality
Exclusive Supplier of DYNO-MILL and DYNA-MIX Technology for North US Announced
Exclusive Supplier of DYNO-MILL and DYNA-MIX Technology for North US Announced
SCHOTT and SINCAD to Ensure High-Quality Pharmaceutical Packaging
SCHOTT and SINCAD to Ensure High-Quality Pharmaceutical Packaging
Complimentary Webinar – How to Deal With the New Post-Market Surveillance Requirements
Complimentary Webinar – How to Deal With the New Post-Market Surveillance Requirements
Take Advantage of NSF’s Supplier Management Training
Take Advantage of NSF’s Supplier Management Training

Suppliers

Whitepapers

Differentiation of THC and CBD cannabis using FTIR5
Differentiation of THC and CBD cannabis using FTIR5
Sanofi Active Ingredient Solutions Product List
Sanofi Active Ingredient Solutions Product List
Sanofi Active Ingredient Solutions
Sanofi Active Ingredient Solutions